Arcellx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Arcellx and other ETFs, options, and stocks.About ACLX
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M.
CEORami Elghandour
CEORami Elghandour
Employees163
Employees163
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2014
Founded2014
Employees163
Employees163
ACLX Key Statistics
Market cap5.00B
Market cap5.00B
Price-Earnings ratio-22.09
Price-Earnings ratio-22.09
Dividend yield—
Dividend yield—
Average volume368.89K
Average volume368.89K
High today$88.06
High today$88.06
Low today$84.51
Low today$84.51
Open price$88.06
Open price$88.06
Volume287.76K
Volume287.76K
52 Week high$107.37
52 Week high$107.37
52 Week low$47.86
52 Week low$47.86
Stock Snapshot
Arcellx(ACLX) stock is priced at $86.55, giving the company a market capitalization of 5B. It carries a P/E multiple of -22.09.
On 2025-11-08, Arcellx(ACLX) stock moved within a range of $84.51 to $88.06. With shares now at $86.55, the stock is trading +2.4% above its intraday low and -1.7% below the session's peak.
Trading volume for Arcellx(ACLX) stock has reached 287.76K, versus its average volume of 368.89K.
The stock's 52-week range extends from a low of $47.86 to a high of $107.37.
The stock's 52-week range extends from a low of $47.86 to a high of $107.37.
Analyst ratings
94%
of 18 ratingsBuy
94.4%
Hold
5.6%
Sell
0%
People also own
Based on the portfolios of people who own ACLX. This list is generated using Robinhood data, and it’s not a recommendation.